Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381)

Author： Lipka Daniel B   Kuck Dirk   Kliem Christian   Gerhauser Clarissa  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.4, 2013-04, pp. : 537-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic compounds: patent evaluation of WO2011011652A1

By Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1491-1495

Informa Healthcare

Access to resources Recommend Favorite

Heterocyclic compounds and their uses: a patent evaluation of WO2010151735A2

By Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 5, 2011-05 ,pp. : 803-806

Informa Healthcare

Access to resources Recommend Favorite

Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218)

By Kessler Benedikt M  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 597-602

Informa Healthcare

Access to resources Recommend Favorite

Polymyxin derivatives: a patent evaluation (WO2012168820)

By Wu Haifan  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

Targeted antimicrobial moieties (WO2010080819): patent evaluation

By Song Zhong-Cheng   Zhu Hai-Liang  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite